Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Sliger, Melissaa | Lander, Timothyb | Murphy, Clairea; b; *
Affiliations: [a] Department of Psychology, San Diego State University, San Diego, CA, USA | [b] University of California Medical Center, San Diego, CA, USA
Correspondence: [*] Corresponding author: Claire Murphy, Ph.D., 6363 Alvarado Court, Suite 101, San Diego State University/University of California, San Diego, CA 92120-4913, USA. Tel.: +1 619 594 4559; Fax: +1 619 594 3773; E-mail: cmurphy@sunstroke.sdsu.edu.
Note: [] Communicated by Grace Petot
Abstract: The present study investigated the effects of the apolipoprotein E (ApoE) ε4 allele, a risk factor for Alzheimer's disease (AD), on olfactory function in Down syndrome (DS). Brain areas critical to olfactory processing, particularly the entorhinal cortex, show the earliest neuropathological changes in AD. Functionally, odor identification has been shown to be impaired in AD and in persons with the ε4 allele. DS is also a risk factor for AD. Thus, we hypothesized greater impairment in ε4 positive DS participants. Olfactory function was assessed with the San Diego Odor Identification Test in 34 participants with DS and 34 normal controls. Genomic DNA was prepared from blood samples to obtain ApoE status for the DS participants. Results indicate (1) that participants with DS had significant deficits in olfactory functioning; and (2) that among DS participants, those with an ε4 allele had poorer odor identification than those without an ε4 allele. The results support the hypothesis that individuals with DS who have an additional genetic risk factor for AD, the ApoE ε4 allele, exhibit greater deficits in odor identification. Areas of the brain involved in odor identification may be particularly affected in individuals with DS who carry the ε4 allele.
Keywords: odor identification, smell, genetic risk, Alzheimer's disease, dementia
DOI: 10.3233/JAD-2004-6407
Journal: Journal of Alzheimer's Disease, vol. 6, no. 4, pp. 397-402, 2004
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl